Riskpilot← Back to searchSign inGet full accessLØKENSKOGEN BOLIG AS
ASActiveOrg 926445855Bogstadveien 27B, 0355 OsloDevelopment of building projects · NACE 6812Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
-185% vs 2023
Equity ratio
2.8%
Financial strength
Net profit 2024
NOK -101K
-185% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -101K | -185% |
| Net profit | NOK -101K | -185% |
| Total assets | NOK 27,4M | +8% |
| Equity | NOK 758K | -12% |
| Employees | 0 | — |
Legal name
LØKENSKOGEN BOLIG AS
Org number
926445855
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
25. januar 2021
Share capital
NOK 1 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Engasjere seg i utvikling av fast eiendom og boliger og andre finansielle aktiviteter i denne forbindelse, så vel som å eie aksjer i forskjellig type virksomheter. Selskapets virksomhet kan bli gjennomført på egenhånd eller gjennom egne datterselskap eller andre partnere.
Address
Bogstadveien 27B, 0355 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −49 | −57 | −35 | −101 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −49 | −57 | −35 | −101 |
| Net financials | −0 | 0 | 0 | 0 |
| Profit before tax | −49 | −57 | −35 | −101 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −49 | −57 | −35 | −101 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 18 683 | 21 200 | 25 292 | 27 441 |
| Equity | −19 | 894 | 859 | 758 |
| Long-term debt | 17 913 | 19 983 | 24 419 | 26 670 |
| Short-term debt | 789 | 323 | 14 | 13 |
| Total debt | 18 702 | 20 306 | 24 434 | 26 683 |
EBITDA margin
-10066600.0%
This company
15.8%
Market median
-63712758% vs market
20212024
Equity ratio
2.8%
This company
38.2%
Market median
-93% vs market
20212024
Return on equity
-13.3%
This company
18.4%
Market median
-172% vs market
20212024
Net profit margin
-10066600.0%
This company
8.1%
Market median
-124279112% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
35.21×
This company
0.62×
Market median
-5579% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AA Chief Executive Officer | Chief Executive Officer | 2021 |
AM Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 19% | 19% | 2023 | |
| Company | 19% | 19% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Aucon As
LØKENSKOGEN BOLIG AS Board members of LØKENSKOGEN BOLIG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Austad | Chief Executive Officer | 0 companies |
| Andres Madalik | Chief Executive Officer | 0 companies |
| Tonu Toomik | Chairman | 0 companies |